

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.58959549 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.38636462 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.41583250 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.40595531 |
| 5 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.29885098 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.24039791 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.24039791 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.21915154 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.18051654 |
| 10 | negative regulation of cell killing (GO:0031342) | 4.18051654 |
| 11 | B cell receptor signaling pathway (GO:0050853) | 4.14853344 |
| 12 | positive thymic T cell selection (GO:0045059) | 4.09538669 |
| 13 | detection of other organism (GO:0098543) | 4.08886195 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 4.01081076 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.91784634 |
| 16 | positive regulation of B cell differentiation (GO:0045579) | 3.87980897 |
| 17 | negative thymic T cell selection (GO:0045060) | 3.87500102 |
| 18 | response to peptidoglycan (GO:0032494) | 3.87394541 |
| 19 | detection of molecule of bacterial origin (GO:0032490) | 3.87321011 |
| 20 | detection of bacterium (GO:0016045) | 3.84624995 |
| 21 | negative T cell selection (GO:0043383) | 3.79844196 |
| 22 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.78365111 |
| 23 | detection of external biotic stimulus (GO:0098581) | 3.71772807 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 3.68815354 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.68815354 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.68815354 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.68815354 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.68815354 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.68815354 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.59358106 |
| 31 | regulation of B cell differentiation (GO:0045577) | 3.55113189 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 3.52261641 |
| 33 | negative regulation of T cell mediated immunity (GO:0002710) | 3.51801605 |
| 34 | mature B cell differentiation (GO:0002335) | 3.50505772 |
| 35 | leukocyte aggregation (GO:0070486) | 3.48426653 |
| 36 | germinal center formation (GO:0002467) | 3.45023932 |
| 37 | microglial cell activation (GO:0001774) | 3.43268402 |
| 38 | thymic T cell selection (GO:0045061) | 3.42871912 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 3.39369956 |
| 40 | histone H3-K36 demethylation (GO:0070544) | 3.36996799 |
| 41 | positive T cell selection (GO:0043368) | 3.36050083 |
| 42 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34868154 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 3.33661702 |
| 44 | B cell homeostasis (GO:0001782) | 3.33362261 |
| 45 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.33055439 |
| 46 | positive regulation of interferon-alpha production (GO:0032727) | 3.30473494 |
| 47 | T cell selection (GO:0045058) | 3.28791390 |
| 48 | negative regulation of B cell proliferation (GO:0030889) | 3.27168042 |
| 49 | NIK/NF-kappaB signaling (GO:0038061) | 3.24105439 |
| 50 | cellular extravasation (GO:0045123) | 3.21496341 |
| 51 | detection of biotic stimulus (GO:0009595) | 3.20675640 |
| 52 | regulation of interferon-alpha production (GO:0032647) | 3.20651995 |
| 53 | histone H3-K4 trimethylation (GO:0080182) | 3.20571890 |
| 54 | neutrophil activation (GO:0042119) | 3.17277255 |
| 55 | response to host (GO:0075136) | 3.16640036 |
| 56 | response to host defenses (GO:0052200) | 3.16640036 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.16640036 |
| 58 | macrophage activation (GO:0042116) | 3.14161363 |
| 59 | macrophage activation involved in immune response (GO:0002281) | 3.09773535 |
| 60 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.07690097 |
| 61 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.03950845 |
| 62 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.02941815 |
| 63 | hepatocyte apoptotic process (GO:0097284) | 3.02423699 |
| 64 | tolerance induction (GO:0002507) | 3.01733678 |
| 65 | positive regulation of histone deacetylation (GO:0031065) | 3.01600403 |
| 66 | response to protozoan (GO:0001562) | 2.96497228 |
| 67 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.94772982 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.94245752 |
| 69 | pinocytosis (GO:0006907) | 2.92722134 |
| 70 | response to muramyl dipeptide (GO:0032495) | 2.90085961 |
| 71 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.89576655 |
| 72 | granulocyte activation (GO:0036230) | 2.88155641 |
| 73 | mitotic sister chromatid cohesion (GO:0007064) | 2.86777489 |
| 74 | defense response to protozoan (GO:0042832) | 2.85360620 |
| 75 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85233754 |
| 76 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.84336463 |
| 77 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.84336463 |
| 78 | cellular response to ethanol (GO:0071361) | 2.84204397 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 2.84031331 |
| 80 | lymphocyte homeostasis (GO:0002260) | 2.83673734 |
| 81 | neutrophil mediated immunity (GO:0002446) | 2.82561722 |
| 82 | definitive hemopoiesis (GO:0060216) | 2.82296610 |
| 83 | regulation of mast cell degranulation (GO:0043304) | 2.82213416 |
| 84 | T cell migration (GO:0072678) | 2.81771831 |
| 85 | myeloid dendritic cell activation (GO:0001773) | 2.81609773 |
| 86 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.80587710 |
| 87 | T-helper 1 type immune response (GO:0042088) | 2.79912762 |
| 88 | regulation of B cell proliferation (GO:0030888) | 2.79437765 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.78897778 |
| 90 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.78366938 |
| 91 | positive regulation of mast cell activation (GO:0033005) | 2.76684432 |
| 92 | regulation of tolerance induction (GO:0002643) | 2.76285978 |
| 93 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.74443870 |
| 94 | regulation of mast cell activation (GO:0033003) | 2.73043966 |
| 95 | mature B cell differentiation involved in immune response (GO:0002313) | 2.72615981 |
| 96 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.72351628 |
| 97 | interferon-gamma production (GO:0032609) | 2.72111424 |
| 98 | response to interleukin-15 (GO:0070672) | 2.72085017 |
| 99 | megakaryocyte development (GO:0035855) | 2.71852416 |
| 100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.71487782 |
| 101 | negative regulation of granulocyte differentiation (GO:0030853) | 2.71345288 |
| 102 | T cell costimulation (GO:0031295) | 2.69305686 |
| 103 | regulation of T cell tolerance induction (GO:0002664) | 2.67074727 |
| 104 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.66672887 |
| 105 | B cell proliferation (GO:0042100) | 2.65325564 |
| 106 | positive regulation of interferon-beta production (GO:0032728) | 2.64997613 |
| 107 | I-kappaB phosphorylation (GO:0007252) | 2.64712148 |
| 108 | lymphocyte costimulation (GO:0031294) | 2.62832769 |
| 109 | regulation of granulocyte differentiation (GO:0030852) | 2.62639776 |
| 110 | leukocyte cell-cell adhesion (GO:0007159) | 2.62449301 |
| 111 | positive regulation of antigen processing and presentation (GO:0002579) | 2.61780424 |
| 112 | T cell homeostasis (GO:0043029) | 2.61157322 |
| 113 | regulation of histone H3-K27 methylation (GO:0061085) | 2.59707480 |
| 114 | positive regulation of macrophage differentiation (GO:0045651) | 2.59440592 |
| 115 | respiratory burst (GO:0045730) | 2.58356245 |
| 116 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.58319738 |
| 117 | B cell mediated immunity (GO:0019724) | 2.57995167 |
| 118 | mast cell activation (GO:0045576) | 2.56920933 |
| 119 | myeloid dendritic cell differentiation (GO:0043011) | 2.56087648 |
| 120 | regulation of necroptotic process (GO:0060544) | 2.55985480 |
| 121 | response to type I interferon (GO:0034340) | 2.55286399 |
| 122 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.53764401 |
| 123 | positive regulation of interleukin-2 production (GO:0032743) | 2.52394514 |
| 124 | positive regulation of granulocyte differentiation (GO:0030854) | 2.52301442 |
| 125 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.51669897 |
| 126 | leukocyte homeostasis (GO:0001776) | 2.50135443 |
| 127 | cellular response to interleukin-15 (GO:0071350) | 2.49022010 |
| 128 | response to host immune response (GO:0052572) | 2.48175845 |
| 129 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.48175845 |
| 130 | growth hormone receptor signaling pathway (GO:0060396) | 2.48035779 |
| 131 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.47422329 |
| 132 | positive regulation of B cell proliferation (GO:0030890) | 2.46908868 |
| 133 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.46399256 |
| 134 | type I interferon signaling pathway (GO:0060337) | 2.44233698 |
| 135 | cellular response to type I interferon (GO:0071357) | 2.44233698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.75227637 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.80905300 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.71863114 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.74533198 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.47899485 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.27699373 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.16881942 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.15627339 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.13788773 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.12461251 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.11728107 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.08546028 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.06892798 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.90976093 |
| 15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.82159302 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.80877346 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74906074 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.69909421 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.55079593 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.33796647 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.24669932 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.23603439 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.17897557 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.15273687 |
| 25 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.14811473 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06369469 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.97702235 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.97203516 |
| 29 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97129007 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.93940614 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87905044 |
| 32 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.86217615 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81311383 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.78542470 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.74049574 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.71262006 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.70775951 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65773563 |
| 39 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.64455922 |
| 40 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64329096 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.63568796 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.62585577 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57229557 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.56929566 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.55757756 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54767637 |
| 47 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.54079326 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.52947610 |
| 49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42999164 |
| 50 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41444365 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40000270 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39352262 |
| 53 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39032680 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30451772 |
| 55 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.29652827 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25943875 |
| 57 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25665038 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18668689 |
| 59 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16825030 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16784686 |
| 61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15756657 |
| 62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11980036 |
| 63 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11707705 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10789207 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10181572 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09742226 |
| 67 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.09319103 |
| 68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09148844 |
| 69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06170191 |
| 70 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04930047 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02491762 |
| 72 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00770708 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.00587662 |
| 74 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99735949 |
| 75 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.99228378 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98718966 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98289520 |
| 78 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.96977044 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95896058 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94930978 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92140019 |
| 82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90280998 |
| 83 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90215968 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90126178 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87939637 |
| 86 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87893369 |
| 87 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.87873534 |
| 88 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.87873534 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87510742 |
| 90 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.87180710 |
| 91 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.85681581 |
| 92 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85091411 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84647788 |
| 94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82566332 |
| 95 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.82356221 |
| 96 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.82288433 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81229933 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81039592 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79733933 |
| 100 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79695124 |
| 101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79183170 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.77901884 |
| 103 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.77871999 |
| 104 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77365818 |
| 105 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.75796152 |
| 106 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.74993505 |
| 107 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74630937 |
| 108 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.72975062 |
| 109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71587607 |
| 110 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.71526028 |
| 111 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70765779 |
| 112 | GATA3_26560356_Chip-Seq_TH1_Human | 0.70301648 |
| 113 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.70126388 |
| 114 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68161911 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.66302741 |
| 116 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.65631521 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.65584750 |
| 118 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.62258647 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.61055798 |
| 120 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60406986 |
| 121 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.59174357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.91746489 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.40077675 |
| 3 | MP0002166_altered_tumor_susceptibility | 3.00071335 |
| 4 | MP0001800_abnormal_humoral_immune | 2.96832632 |
| 5 | MP0001790_abnormal_immune_system | 2.92977065 |
| 6 | MP0005387_immune_system_phenotype | 2.92977065 |
| 7 | MP0003303_peritoneal_inflammation | 2.83805081 |
| 8 | MP0000685_abnormal_immune_system | 2.81207850 |
| 9 | MP0005671_abnormal_response_to | 2.76794050 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.73332472 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.64160438 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.56224418 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.51342673 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.48262765 |
| 15 | MP0002006_tumorigenesis | 2.46448246 |
| 16 | MP0003436_decreased_susceptibility_to | 2.42003038 |
| 17 | MP0002723_abnormal_immune_serum | 2.36197086 |
| 18 | MP0001873_stomach_inflammation | 2.35687097 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.32364535 |
| 20 | MP0002419_abnormal_innate_immunity | 2.31259647 |
| 21 | MP0001819_abnormal_immune_cell | 2.29889647 |
| 22 | MP0004510_myositis | 2.20528387 |
| 23 | MP0002398_abnormal_bone_marrow | 2.13257365 |
| 24 | MP0005025_abnormal_response_to | 2.06185433 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 1.94942522 |
| 26 | MP0000716_abnormal_immune_system | 1.94252479 |
| 27 | MP0004947_skin_inflammation | 1.93899502 |
| 28 | MP0008260_abnormal_autophagy | 1.91679017 |
| 29 | MP0002405_respiratory_system_inflammati | 1.88627455 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.88161084 |
| 31 | MP0009785_altered_susceptibility_to | 1.84088553 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.83937850 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.81294146 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 1.80521677 |
| 35 | MP0005310_abnormal_salivary_gland | 1.74913719 |
| 36 | MP0008057_abnormal_DNA_replication | 1.69094934 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.68991340 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.68474849 |
| 39 | MP0002722_abnormal_immune_system | 1.67591069 |
| 40 | MP0006082_CNS_inflammation | 1.64700985 |
| 41 | MP0009278_abnormal_bone_marrow | 1.60800827 |
| 42 | MP0001853_heart_inflammation | 1.60463297 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.58677737 |
| 44 | MP0005451_abnormal_body_composition | 1.57893623 |
| 45 | MP0002429_abnormal_blood_cell | 1.57174292 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.52457282 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.51240173 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.51240173 |
| 49 | MP0002009_preneoplasia | 1.51120052 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.49958905 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.46782066 |
| 52 | MP0003045_fibrosis | 1.43682622 |
| 53 | MP0005076_abnormal_cell_differentiation | 1.39093402 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.34722726 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.33195007 |
| 56 | MP0004381_abnormal_hair_follicle | 1.31183888 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.31137338 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.30878428 |
| 59 | MP0010307_abnormal_tumor_latency | 1.30347049 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.30216473 |
| 61 | MP0003724_increased_susceptibility_to | 1.29601203 |
| 62 | MP0002933_joint_inflammation | 1.26194925 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.26000872 |
| 64 | MP0000015_abnormal_ear_pigmentation | 1.25053632 |
| 65 | MP0003866_abnormal_defecation | 1.24968846 |
| 66 | MP0003448_altered_tumor_morphology | 1.17431684 |
| 67 | MP0003787_abnormal_imprinting | 1.16292018 |
| 68 | MP0003091_abnormal_cell_migration | 1.15668676 |
| 69 | MP0002254_reproductive_system_inflammat | 1.13589308 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 1.13537829 |
| 71 | MP0001851_eye_inflammation | 1.13341877 |
| 72 | MP0003828_pulmonary_edema | 1.13180267 |
| 73 | MP0002998_abnormal_bone_remodeling | 1.10161699 |
| 74 | MP0004883_abnormal_blood_vessel | 1.08469805 |
| 75 | MP0008004_abnormal_stomach_pH | 1.07672011 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 1.06144862 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 1.05780980 |
| 78 | MP0000858_altered_metastatic_potential | 0.98398938 |
| 79 | MP0000490_abnormal_crypts_of | 0.97696857 |
| 80 | MP0010234_abnormal_vibrissa_follicle | 0.94363451 |
| 81 | MP0008469_abnormal_protein_level | 0.92819175 |
| 82 | MP0003690_abnormal_glial_cell | 0.89349889 |
| 83 | MP0005164_abnormal_response_to | 0.89023091 |
| 84 | MP0005023_abnormal_wound_healing | 0.87031171 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 0.87021475 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.85449346 |
| 87 | MP0000383_abnormal_hair_follicle | 0.84433969 |
| 88 | MP0002019_abnormal_tumor_incidence | 0.82220162 |
| 89 | MP0009115_abnormal_fat_cell | 0.81592638 |
| 90 | MP0000371_diluted_coat_color | 0.81435725 |
| 91 | MP0010678_abnormal_skin_adnexa | 0.81189971 |
| 92 | MP0000604_amyloidosis | 0.81063205 |
| 93 | MP0002132_abnormal_respiratory_system | 0.81041393 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.79908023 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.78689313 |
| 96 | MP0003075_altered_response_to | 0.78604741 |
| 97 | MP0001879_abnormal_lymphatic_vessel | 0.76158158 |
| 98 | MP0000249_abnormal_blood_vessel | 0.73634631 |
| 99 | MP0004130_abnormal_muscle_cell | 0.73611906 |
| 100 | MP0004484_altered_response_of | 0.71883665 |
| 101 | MP0003252_abnormal_bile_duct | 0.71696647 |
| 102 | MP0001216_abnormal_epidermal_layer | 0.71442292 |
| 103 | MP0000733_abnormal_muscle_development | 0.71386284 |
| 104 | MP0002332_abnormal_exercise_endurance | 0.70636226 |
| 105 | MP0009764_decreased_sensitivity_to | 0.69998738 |
| 106 | MP0001191_abnormal_skin_condition | 0.69442695 |
| 107 | MP0002928_abnormal_bile_duct | 0.68320976 |
| 108 | MP0005409_darkened_coat_color | 0.67866523 |
| 109 | MP0009763_increased_sensitivity_to | 0.66574091 |
| 110 | MP0008877_abnormal_DNA_methylation | 0.65510268 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.63997774 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63985430 |
| 113 | MP0005621_abnormal_cell_physiology | 0.63203455 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.61822656 |
| 115 | MP0003795_abnormal_bone_structure | 0.60294100 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.59878247 |
| 117 | MP0000609_abnormal_liver_physiology | 0.58882297 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.58160630 |
| 119 | MP0001663_abnormal_digestive_system | 0.57481548 |
| 120 | MP0005166_decreased_susceptibility_to | 0.56324488 |
| 121 | MP0005390_skeleton_phenotype | 0.54023989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.47287780 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.21806017 |
| 3 | Abnormality of the fingertips (HP:0001211) | 4.10113402 |
| 4 | Recurrent viral infections (HP:0004429) | 4.09939805 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.01943421 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.00144430 |
| 7 | Agammaglobulinemia (HP:0004432) | 3.77532398 |
| 8 | Colitis (HP:0002583) | 3.62306894 |
| 9 | Cellulitis (HP:0100658) | 3.57218290 |
| 10 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.40303711 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 3.40303711 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 3.39233608 |
| 13 | IgM deficiency (HP:0002850) | 3.35367050 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 3.34213763 |
| 15 | Inflammation of the large intestine (HP:0002037) | 3.32439691 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.20533473 |
| 17 | Recurrent skin infections (HP:0001581) | 3.17496153 |
| 18 | Gastrointestinal stroma tumor (HP:0100723) | 3.07720531 |
| 19 | Gastrointestinal inflammation (HP:0004386) | 3.06079226 |
| 20 | Vasculitis (HP:0002633) | 2.99309677 |
| 21 | T lymphocytopenia (HP:0005403) | 2.99062396 |
| 22 | Recurrent bronchitis (HP:0002837) | 2.98847106 |
| 23 | Meningitis (HP:0001287) | 2.95520539 |
| 24 | Myositis (HP:0100614) | 2.95204623 |
| 25 | Abnormality of T cell number (HP:0011839) | 2.94768146 |
| 26 | Epistaxis (HP:0000421) | 2.87508867 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 2.87152829 |
| 28 | Chest pain (HP:0100749) | 2.81350900 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 2.80410102 |
| 30 | Chronic otitis media (HP:0000389) | 2.79612045 |
| 31 | Lymphopenia (HP:0001888) | 2.77730552 |
| 32 | Periodontitis (HP:0000704) | 2.76702775 |
| 33 | Urticaria (HP:0001025) | 2.73668067 |
| 34 | Thyroiditis (HP:0100646) | 2.71446082 |
| 35 | Acute myeloid leukemia (HP:0004808) | 2.70810716 |
| 36 | Osteomyelitis (HP:0002754) | 2.69746416 |
| 37 | Volvulus (HP:0002580) | 2.66816385 |
| 38 | Autoimmune hemolytic anemia (HP:0001890) | 2.64193829 |
| 39 | Increased IgE level (HP:0003212) | 2.63143893 |
| 40 | Macroorchidism (HP:0000053) | 2.62998402 |
| 41 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.61908929 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.61339905 |
| 43 | Hematochezia (HP:0002573) | 2.59248680 |
| 44 | Retrobulbar optic neuritis (HP:0100654) | 2.57903875 |
| 45 | Optic neuritis (HP:0100653) | 2.57903875 |
| 46 | Abnormality of macrophages (HP:0004311) | 2.57502030 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.53192654 |
| 48 | Pustule (HP:0200039) | 2.50741322 |
| 49 | Pulmonary embolism (HP:0002204) | 2.49059455 |
| 50 | Gingivitis (HP:0000230) | 2.47375514 |
| 51 | Absent frontal sinuses (HP:0002688) | 2.47164718 |
| 52 | IgA deficiency (HP:0002720) | 2.43804151 |
| 53 | Verrucae (HP:0200043) | 2.40822586 |
| 54 | Papilloma (HP:0012740) | 2.40822586 |
| 55 | B lymphocytopenia (HP:0010976) | 2.40694349 |
| 56 | Abnormality of B cell number (HP:0010975) | 2.40694349 |
| 57 | Arterial thrombosis (HP:0004420) | 2.39885348 |
| 58 | Thoracic kyphosis (HP:0002942) | 2.39316310 |
| 59 | Chronic diarrhea (HP:0002028) | 2.38436170 |
| 60 | Abnormality of T cells (HP:0002843) | 2.37513858 |
| 61 | Orchitis (HP:0100796) | 2.35071194 |
| 62 | Gangrene (HP:0100758) | 2.34328939 |
| 63 | Myocardial infarction (HP:0001658) | 2.33591170 |
| 64 | Emphysema (HP:0002097) | 2.33175262 |
| 65 | Eosinophilia (HP:0001880) | 2.31878672 |
| 66 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.31606999 |
| 67 | Slow saccadic eye movements (HP:0000514) | 2.30781652 |
| 68 | Recurrent pneumonia (HP:0006532) | 2.29224053 |
| 69 | Fatigue (HP:0012378) | 2.28178709 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.23883085 |
| 71 | Abnormality of the thoracic spine (HP:0100711) | 2.23400811 |
| 72 | Recurrent sinusitis (HP:0011108) | 2.21942094 |
| 73 | Disinhibition (HP:0000734) | 2.21111653 |
| 74 | Chronic obstructive pulmonary disease (HP:0006510) | 2.20772215 |
| 75 | Obstructive lung disease (HP:0006536) | 2.20772215 |
| 76 | Prolonged bleeding time (HP:0003010) | 2.18007258 |
| 77 | Abnormality of the pleura (HP:0002103) | 2.16278164 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 2.13775400 |
| 79 | Lip pit (HP:0100267) | 2.12382869 |
| 80 | Papilledema (HP:0001085) | 2.11108134 |
| 81 | Abnormality of the prostate (HP:0008775) | 2.10882938 |
| 82 | Gingival bleeding (HP:0000225) | 2.10820830 |
| 83 | Spondylolisthesis (HP:0003302) | 2.10406264 |
| 84 | Interstitial pulmonary disease (HP:0006530) | 2.09172819 |
| 85 | Stomatitis (HP:0010280) | 2.08747282 |
| 86 | Leukocytosis (HP:0001974) | 2.07692557 |
| 87 | Abnormality of the peritoneum (HP:0002585) | 2.07156807 |
| 88 | Recurrent lower respiratory tract infections (HP:0002783) | 2.06153962 |
| 89 | Abnormality of T cell physiology (HP:0011840) | 2.05589328 |
| 90 | Restrictive lung disease (HP:0002091) | 2.05372420 |
| 91 | Prostate neoplasm (HP:0100787) | 2.03173778 |
| 92 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.01183266 |
| 93 | Joint swelling (HP:0001386) | 1.99666911 |
| 94 | Subacute progressive viral hepatitis (HP:0006572) | 1.99587075 |
| 95 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.98886234 |
| 96 | Long eyelashes (HP:0000527) | 1.97290305 |
| 97 | Peritonitis (HP:0002586) | 1.96119506 |
| 98 | Abnormality of eosinophils (HP:0001879) | 1.95553887 |
| 99 | Osteolytic defects of the hand bones (HP:0009699) | 1.94858757 |
| 100 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.94858757 |
| 101 | Asymmetry of the thorax (HP:0001555) | 1.94822411 |
| 102 | Increased IgM level (HP:0003496) | 1.94382894 |
| 103 | Prominent nose (HP:0000448) | 1.93431823 |
| 104 | Sepsis (HP:0100806) | 1.92529449 |
| 105 | IgG deficiency (HP:0004315) | 1.92462576 |
| 106 | Hypoplasia of the thymus (HP:0000778) | 1.92286970 |
| 107 | Keratoconjunctivitis sicca (HP:0001097) | 1.92013324 |
| 108 | Acute hepatic failure (HP:0006554) | 1.91246130 |
| 109 | Anorexia (HP:0002039) | 1.89243875 |
| 110 | Viral hepatitis (HP:0006562) | 1.87688593 |
| 111 | Leukopenia (HP:0001882) | 1.87257001 |
| 112 | Granulocytopenia (HP:0001913) | 1.86778999 |
| 113 | Keratoconjunctivitis (HP:0001096) | 1.86698351 |
| 114 | Severe combined immunodeficiency (HP:0004430) | 1.85918484 |
| 115 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.84424528 |
| 116 | Lymphoma (HP:0002665) | 1.84237499 |
| 117 | Thick nail (HP:0001805) | 1.84023005 |
| 118 | Vertigo (HP:0002321) | 1.83410164 |
| 119 | Encephalitis (HP:0002383) | 1.82969116 |
| 120 | Skin ulcer (HP:0200042) | 1.82901296 |
| 121 | Limited elbow extension (HP:0001377) | 1.81956085 |
| 122 | Urethral obstruction (HP:0000796) | 1.81884476 |
| 123 | Hemoptysis (HP:0002105) | 1.81853700 |
| 124 | Glomerulopathy (HP:0100820) | 1.81615485 |
| 125 | Skin rash (HP:0000988) | 1.78815219 |
| 126 | Alveolar cell carcinoma (HP:0006519) | 1.76965393 |
| 127 | Thrombophlebitis (HP:0004418) | 1.76227694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.99801342 |
| 2 | STK10 | 2.69486042 |
| 3 | RIPK4 | 2.58392472 |
| 4 | PRPF4B | 2.56790079 |
| 5 | TYK2 | 2.50925964 |
| 6 | MAP3K14 | 2.49795393 |
| 7 | TAOK3 | 2.40915576 |
| 8 | MAP3K13 | 2.35691733 |
| 9 | JAK3 | 2.29874603 |
| 10 | CAMK1D | 2.14585215 |
| 11 | KIT | 2.09294641 |
| 12 | BMPR2 | 2.07672168 |
| 13 | JAK1 | 2.07281100 |
| 14 | TXK | 1.97710418 |
| 15 | CDK12 | 1.97482104 |
| 16 | CAMK1G | 1.88904640 |
| 17 | IKBKE | 1.80674179 |
| 18 | FGFR3 | 1.79489510 |
| 19 | TGFBR2 | 1.79015935 |
| 20 | IRAK4 | 1.77794011 |
| 21 | TEC | 1.74297499 |
| 22 | ITK | 1.73897260 |
| 23 | TBK1 | 1.72895264 |
| 24 | CSF1R | 1.71842957 |
| 25 | MAP3K10 | 1.68696898 |
| 26 | SIK2 | 1.66319682 |
| 27 | BLK | 1.66142918 |
| 28 | EPHB1 | 1.54752735 |
| 29 | HCK | 1.52986529 |
| 30 | SYK | 1.52528283 |
| 31 | CSK | 1.51918858 |
| 32 | FGFR4 | 1.51705532 |
| 33 | BTK | 1.51044713 |
| 34 | ZAP70 | 1.44403357 |
| 35 | IKBKB | 1.39102851 |
| 36 | EEF2K | 1.33145253 |
| 37 | TRPM7 | 1.31870187 |
| 38 | RIPK1 | 1.30668697 |
| 39 | CHUK | 1.29665793 |
| 40 | NUAK1 | 1.28728141 |
| 41 | PIK3CG | 1.25291443 |
| 42 | * LCK | 1.20989112 |
| 43 | MARK3 | 1.18901219 |
| 44 | DMPK | 1.18146098 |
| 45 | MAP3K2 | 1.14548883 |
| 46 | IRAK1 | 1.12698126 |
| 47 | GRK6 | 1.12470674 |
| 48 | LRRK2 | 1.11160249 |
| 49 | MAP3K1 | 1.05379716 |
| 50 | MAP3K3 | 1.03978042 |
| 51 | CDC42BPA | 1.03336446 |
| 52 | IRAK3 | 1.01512804 |
| 53 | FES | 1.01388105 |
| 54 | PIM1 | 0.99841752 |
| 55 | CDK9 | 0.99079971 |
| 56 | PDGFRB | 0.98138381 |
| 57 | TTN | 0.96743587 |
| 58 | FRK | 0.96435802 |
| 59 | CDK6 | 0.95088779 |
| 60 | BRD4 | 0.94925530 |
| 61 | CLK1 | 0.94455136 |
| 62 | PTK6 | 0.92093208 |
| 63 | LYN | 0.91527951 |
| 64 | ERN1 | 0.89906938 |
| 65 | PRKCQ | 0.88623496 |
| 66 | NLK | 0.88386874 |
| 67 | SGK2 | 0.88139447 |
| 68 | YES1 | 0.86697845 |
| 69 | JAK2 | 0.86537795 |
| 70 | NEK9 | 0.86071243 |
| 71 | STK4 | 0.84183262 |
| 72 | MAP3K6 | 0.82369896 |
| 73 | MAP3K7 | 0.82368166 |
| 74 | CAMKK2 | 0.81945154 |
| 75 | HIPK2 | 0.80100163 |
| 76 | TRIB3 | 0.75783690 |
| 77 | STK3 | 0.72971309 |
| 78 | PDK1 | 0.69548876 |
| 79 | MAPK7 | 0.69494121 |
| 80 | TNK2 | 0.69057039 |
| 81 | KSR2 | 0.67268609 |
| 82 | MST4 | 0.65675145 |
| 83 | MAPK12 | 0.65594564 |
| 84 | PRKAA2 | 0.65272217 |
| 85 | EPHA3 | 0.64889223 |
| 86 | IRAK2 | 0.63618067 |
| 87 | RPS6KA4 | 0.63300004 |
| 88 | PKN2 | 0.62827177 |
| 89 | FGR | 0.62280420 |
| 90 | PRKCH | 0.61269467 |
| 91 | MATK | 0.60943109 |
| 92 | CAMKK1 | 0.60509768 |
| 93 | EGFR | 0.60167426 |
| 94 | INSRR | 0.60133523 |
| 95 | RET | 0.57689004 |
| 96 | ABL1 | 0.56575355 |
| 97 | PTK2B | 0.56200411 |
| 98 | CDK4 | 0.55027593 |
| 99 | SIK3 | 0.54974025 |
| 100 | ATR | 0.54900862 |
| 101 | ALK | 0.54861832 |
| 102 | SGK3 | 0.54124668 |
| 103 | FGFR2 | 0.53737674 |
| 104 | STK24 | 0.51228255 |
| 105 | STK38 | 0.50079880 |
| 106 | MAP3K5 | 0.49626517 |
| 107 | NEK2 | 0.49465764 |
| 108 | MAPK11 | 0.48550326 |
| 109 | WNK1 | 0.48357269 |
| 110 | MAP2K3 | 0.47995694 |
| 111 | FLT3 | 0.46171903 |
| 112 | SCYL2 | 0.46046529 |
| 113 | MELK | 0.45293783 |
| 114 | RAF1 | 0.44638823 |
| 115 | MAP3K8 | 0.41308849 |
| 116 | STK11 | 0.40589219 |
| 117 | TIE1 | 0.39060105 |
| 118 | RPS6KC1 | 0.37111078 |
| 119 | RPS6KL1 | 0.37111078 |
| 120 | IGF1R | 0.35851841 |
| 121 | MAPKAPK2 | 0.35246099 |
| 122 | MTOR | 0.33202661 |
| 123 | INSR | 0.33015443 |
| 124 | PDPK1 | 0.32542377 |
| 125 | RPS6KA6 | 0.32122393 |
| 126 | PRKD2 | 0.31373878 |
| 127 | * FYN | 0.31294827 |
| 128 | GRK7 | 0.31212115 |
| 129 | BMX | 0.30409280 |
| 130 | MARK2 | 0.30135247 |
| 131 | TAOK1 | 0.29517612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.98353839 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.95541437 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.55492594 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.40694543 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.36695368 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.99436315 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98804414 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.94864235 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.91860762 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.85679523 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.78569828 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.75685871 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.74220483 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66639151 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66146594 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62867079 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.48595201 |
| 18 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48083107 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47351107 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.46315847 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45674225 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45038733 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.44742767 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.42198883 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40671687 |
| 26 | Hepatitis B_Homo sapiens_hsa05161 | 1.34565736 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34268443 |
| 28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.33514720 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.32767260 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32667957 |
| 31 | Platelet activation_Homo sapiens_hsa04611 | 1.31401017 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27146613 |
| 33 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.26006302 |
| 34 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.22414186 |
| 35 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.21396986 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17759672 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.16282128 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.15835160 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.14954294 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.14549539 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13066529 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.12172544 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.11323489 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10054949 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06887662 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00091446 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 0.99620164 |
| 48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99257918 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.96219171 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95031473 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93880127 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.93214729 |
| 53 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.92469023 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91301234 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90974835 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.88772232 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87699017 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87481733 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85854610 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84515432 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 0.81177599 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79176336 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78671139 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77416086 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75251001 |
| 66 | Prostate cancer_Homo sapiens_hsa05215 | 0.74272645 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74159793 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72751098 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.72653560 |
| 70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71891550 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70462709 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70136015 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.68973442 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.67514729 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66934049 |
| 76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66886251 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66562037 |
| 78 | Focal adhesion_Homo sapiens_hsa04510 | 0.66228663 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.64821737 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64530123 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62636469 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.62583553 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.62134556 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61861283 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61004874 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60939120 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60577637 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.60370771 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60049705 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.58668345 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57872624 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57785115 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57424657 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57118737 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.56913635 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56820334 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55652520 |
| 98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55619891 |
| 99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54794916 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53748117 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53460710 |
| 102 | Long-term potentiation_Homo sapiens_hsa04720 | 0.53399039 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52777592 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51817640 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50961561 |
| 106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49501079 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48269440 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48229378 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47658995 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46452436 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43478669 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42087782 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37202787 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34374554 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33299074 |

